CYP8B1 and hepatocellular carcinoma: In parallel, relevant experiments reported that elevated levels of CDCA in the livers of mice treated with tauro-chendoxycholic acid (TCDCA) and tauro-ursodeoxycholic acid (TUDCA) inhibit the expression of CYP8B1 in the classical pathway and further promote the development of HCC [60].